Las Vegas, NV -- (SBWIRE) -- 01/07/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: ROMARCO MIN INC NEW(OTCMKTS:RTRAF), North American Oil & Gas Corp(OTCBB:NAMG), Arch Therapeutics Inc(OTCBB:ARTH), Neutra Corp(OTCMKTS:NTRR).
ROMARCO MIN INC NEW(OTCMKTS:RTRAF) ended higher +2.63% and complete the day at $0.390. The total number of shares changed hands during the day was 183,882. After opening at $0.39, the stock hit as high as $0.41. However, it traded between $0.30 and $1.07 over the last twelve months. Romarco Minerals Inc., an exploration and development stage company, engages in the acquisition, exploration, and development of precious metals mineral properties in the United States. It primarily holds interest in the Haile Gold Mine property located in Lancaster County, South Carolina. Romarco Minerals Inc. is headquartered in Toronto, Canada.
For How Long RTRAF will Fight for Profitability? Read This Trend Analysis report
North American Oil & Gas Corp(OTCBB:NAMG) closed yesterday at $0.400, a -13.23% decrease. Around 746,976 shares were traded, beating an-average trading volume of 521,127 shares. The company is now valued at around $24.13 million. North American Oil & Gas Corp. (NAMOG) is a development-stage company. The Company is engaged in oil and gas exploration in California, through its subsidiary Lani.
Has NAMG Found The Bottom And Ready To Gain Momentum? Find Out Here
Arch Therapeutics Inc(OTCBB:ARTH) moved -5.95 percent lower at $0.395 and traded between $0.38 and $0.44 after opening the day at $0.42. Its performance over the last five days remained 58%, which stands at 140.12% for a month. Going back further than one month, 1-year performance after recent close was 21.54%.Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch’s products are in preclinical development.
Why Should Investors Buy ARTH After the Recent Fall? Just Go Here and Find Out
Neutra Corp(OTCMKTS:NTRR) shares rose, gaining +0.68 percent to close at $0.442. The stock is up around 40.32% this year and -55.8% for the last 12 months. Around 253,084 shares changed hands yesterday, higher from an-average trading volume of 158,825 shares. Neutra Corp. is a development-stage company. The Company’s business and registered office is located in Sarasota, Florida. The Company’s intended private label products consists of aging, cognitive support, antioxidants/flavonoids, circulatory support, detoxification support, endocrine support, essential fatty acids, gastrointestinal support, immune support, men’s health, minerals, mood/sleep support, multiples, musculoskeletal support, neurological support, proteins/amino acids, vitamins, women’s health and veterinary products.
Why Should Investors Buy NTRR After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)